Evidence map›Paper›PMID 41226352›Full record

ArticleInternational journal of molecular sciences2025

The Clinical Significance of GRP78 in COVID-19 Pneumonia Across Two Regional Cohorts.

Steliyan Petrov, Martina Bozhkova, Stanislava Popova-Belova, Mariela Geneva-Popova, Tanya Deneva, İbrahim Türkçüer, Aylin Köseler

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Steliyan PetrovDepartment of Medical Microbiology and Immunology-"Prof. Dr. Elissay Yanev", Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-0522-5682
Martina BozhkovaDepartment of Medical Microbiology and Immunology-"Prof. Dr. Elissay Yanev", Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-4230-3299
Stanislava Popova-BelovaDepartment of Propedeutics of Internal Diseases "Anton Mitov", Medical University-Plovdiv, General Hospital "Sv. Georgi", 4002 Plovdiv, Bulgaria.
Mariela Geneva-PopovaDepartment of Propedeutics of Internal Diseases "Anton Mitov", Medical University-Plovdiv, General Hospital "Sv. Georgi", 4002 Plovdiv, Bulgaria.
Tanya DenevaDepartment of Clinical Laboratory, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.
İbrahim TürkçüerDepartment of Emergency, Pamukkale University Faculty of Medicine, 20190 Denizli, Türkiye.
Aylin KöselerDepartment of Biophysics, Pamukkale University Faculty of Medicine, 20190 Denizli, Türkiye.ORCID 0000-0003-4832-0436

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 pneumonia remains a major driver of morbidity and mortality worldwide, with outcomes influenced by demographic, clinical, and systemic factors. Glucose-regulated protein 78 (GRP78) has emerged as a potential biomarker of disease severity, but its clinical significance across different populations remains underexplored. We conducted a retrospective cohort study including 83 hospitalized COVID-19 patients from General Hospital "Sv. Georgi", Plovdiv, Bulgaria, and 97 from Denizli, Türkiye. Pneumonia diagnosis was based on clinical, laboratory, and radiological criteria. Patient demographics and biomarkers (CRP, D-dimer, oxygen saturation, lymphocyte count, and serum GRP78) were compared between cohorts. Statistical analyses included Mann-Whitney U,

Indexed as

COVID-19Heat-Shock ProteinsAdultAgedAged, 80 and overBiomarkersClinical RelevanceC-Reactive ProteinEndoplasmic Reticulum Chaperone BiPFemaleFibrin Fibrinogen Degradation ProductsHumansMaleMiddle AgedRetrospective StudiesSARS-CoV-2BiomarkersC-Reactive ProteinEndoplasmic Reticulum Chaperone BiPFibrin Fibrinogen Degradation Productsfibrin fragment DHeat-Shock ProteinsHSPA5 protein, humanbiomarkersCOVID-19GRP78pneumoniaSARS-CoV-2

Identifiers

PMID41226352
PMCPMC12607724

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.